182 related articles for article (PubMed ID: 19171922)
1. Process validation and screen reproducibility in high-throughput screening.
Coma I; Clark L; Diez E; Harper G; Herranz J; Hofmann G; Lennon M; Richmond N; Valmaseda M; Macarron R
J Biomol Screen; 2009 Jan; 14(1):66-76. PubMed ID: 19171922
[TBL] [Abstract][Full Text] [Related]
2. Improved statistical methods for hit selection in high-throughput screening.
Brideau C; Gunter B; Pikounis B; Liaw A
J Biomol Screen; 2003 Dec; 8(6):634-47. PubMed ID: 14711389
[TBL] [Abstract][Full Text] [Related]
3. Statistical and graphical methods for quality control determination of high-throughput screening data.
Gunter B; Brideau C; Pikounis B; Liaw A
J Biomol Screen; 2003 Dec; 8(6):624-33. PubMed ID: 14711388
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
[TBL] [Abstract][Full Text] [Related]
5. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
Shun TY; Lazo JS; Sharlow ER; Johnston PA
J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
[TBL] [Abstract][Full Text] [Related]
6. High-throughput siRNA-based functional target validation.
Xin H; Bernal A; Amato FA; Pinhasov A; Kauffman J; Brenneman DE; Derian CK; Andrade-Gordon P; Plata-Salamán CR; Ilyin SE
J Biomol Screen; 2004 Jun; 9(4):286-93. PubMed ID: 15191645
[TBL] [Abstract][Full Text] [Related]
7. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening: update on practices and success.
Fox S; Farr-Jones S; Sopchak L; Boggs A; Nicely HW; Khoury R; Biros M
J Biomol Screen; 2006 Oct; 11(7):864-9. PubMed ID: 16973922
[TBL] [Abstract][Full Text] [Related]
9. Statistical analysis of systematic errors in high-throughput screening.
Kevorkov D; Makarenkov V
J Biomol Screen; 2005 Sep; 10(6):557-67. PubMed ID: 16103415
[TBL] [Abstract][Full Text] [Related]
10. Streamlining lead discovery by aligning in silico and high-throughput screening.
Davies JW; Glick M; Jenkins JL
Curr Opin Chem Biol; 2006 Aug; 10(4):343-51. PubMed ID: 16822701
[TBL] [Abstract][Full Text] [Related]
11. "Plate cherry picking": a novel semi-sequential screening paradigm for cheaper, faster, information-rich compound selection.
Crisman TJ; Jenkins JL; Parker CN; Hill WA; Bender A; Deng Z; Nettles JH; Davies JW; Glick M
J Biomol Screen; 2007 Apr; 12(3):320-7. PubMed ID: 17438067
[TBL] [Abstract][Full Text] [Related]
12. Strategies to generate biological reagents for kinase drug discovery.
Hassan NJ; Gul S
Expert Opin Drug Discov; 2011 Dec; 6(12):1215-25. PubMed ID: 22647062
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of machine-learning and chemometric tools for analysis of in-vivo high-throughput screening data.
Simmons K; Kinney J; Owens A; Kleier D; Bloch K; Argentar D; Walsh A; Vaidyanathan G
J Chem Inf Model; 2008 Aug; 48(8):1663-8. PubMed ID: 18681397
[TBL] [Abstract][Full Text] [Related]
14. Selection criteria for drug-like compounds.
Muegge I
Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
[TBL] [Abstract][Full Text] [Related]
15. High-throughput screening in academia: the Harvard experience.
Stein RL
J Biomol Screen; 2003 Dec; 8(6):615-9. PubMed ID: 14711386
[TBL] [Abstract][Full Text] [Related]
16. High-content micronucleus assay in genotoxicity profiling: initial-stage development and some applications in the investigative/lead-finding studies in drug discovery.
Mondal MS; Gabriels J; McGinnis C; Magnifico M; Marsilje TH; Urban L; Collis A; Bojanic D; Biller SA; Frieauff W; Martus HJ; Suter W; Bentley P
Toxicol Sci; 2010 Nov; 118(1):71-85. PubMed ID: 20631060
[TBL] [Abstract][Full Text] [Related]
17. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening.
Zhang JH; Roddy TP; Ho PI; Horvath CR; Vickers C; Stout S; Hubbard B; Wang YK; Hill WA; Bojanic D
J Biomol Screen; 2010 Jul; 15(6):695-702. PubMed ID: 20484097
[TBL] [Abstract][Full Text] [Related]
18. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
[TBL] [Abstract][Full Text] [Related]
19. Affinity-based screening techniques for enhancing lead discovery.
Comess KM; Schurdak ME
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
[TBL] [Abstract][Full Text] [Related]
20. Smart screening: approaches to efficient HTS.
Engels MF; Venkatarangan P
Curr Opin Drug Discov Devel; 2001 May; 4(3):275-83. PubMed ID: 11560058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
